Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
154 stocks in the US match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| IDXX | IDEXX Laboratories, Inc. | Healthcare | $43.66B | $553.44 | −28.12% | −2.83% |
| IQV | IQVIA Holdings Inc. | Healthcare | $43.04B | $261.51 | −0.38% | +7.64% |
| QTS.DE | IQVIA Holdings Inc. | Healthcare | $43.01B | 222.10 EUR | −4.04% | +19.34% |
| V2EE34.SA | Veeva Systems Inc. | Healthcare | $41.01B | 43.28 BRL | −20.22% | +37.40% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| WAT | Waters Corporation | Healthcare | $40.67B | $414.17 | −1.79% | +7.88% |
| VEE.DE | Veeva Systems Inc. | Healthcare | $40.02B | 211.20 EUR | −18.49% | +15.44% |
| VEEV | Veeva Systems Inc. | Healthcare | $39.78B | $244.91 | −21.12% | +21.72% |
| A1GI34.SA | Agilent Technologies, Inc. | Healthcare | $39.64B | 72.26 BRL | −82.41% | +7.99% |
| WATC34.SA | Waters Corporation | Healthcare | $36.35B | 476.58 BRL | −11.74% | 0.00% |
| RPRX | Royalty Pharma plc | Healthcare | $35.71B | $61.80 | −1.05% | +3.05% |
| RMD | ResMed Inc. | Healthcare | $34.13B | $235.69 | −19.78% | +12.79% |
| I1LM34.SA | Illumina, Inc. | Healthcare | $34.10B | 232.57 BRL | 0.00% | +19.43% |
| ILU.DE | Illumina, Inc. | Healthcare | $34.08B | 193.08 EUR | 0.00% | +13.91% |
| RMD.AX | ResMed Inc. | Healthcare | $34.05B | 32.47 AUD | −28.24% | +8.27% |
| ILMN | Illumina, Inc. | Healthcare | $33.95B | $224.84 | −1.24% | +16.51% |
| D1EX34.SA | DexCom, Inc. | Healthcare | $33.75B | 9.21 BRL | −3.76% | +28.45% |
| DXCM | DexCom, Inc. | Healthcare | $33.65B | $88.96 | −3.92% | +18.85% |
| DC4.DE | DexCom, Inc. | Healthcare | $33.35B | 77.60 EUR | −2.51% | +16.52% |
| GEHC | GE HealthCare Technologies Inc. | Healthcare | $33.35B | $73.31 | −18.34% | +14.35% |
| BIIB | Biogen Inc. | Healthcare | $32.66B | $221.07 | −0.80% | +7.52% |
| C1NC34.SA | Centene Corporation | Healthcare | $32.65B | 340.30 BRL | −2.85% | −2.49% |
| BIIB34.SA | Biogen Inc. | Healthcare | $32.56B | 188.29 BRL | −1.42% | +9.47% |
| IDP.DE | Biogen Inc. | Healthcare | $32.39B | 190.12 EUR | −1.49% | +0.21% |
| CNC | Centene Corporation | Healthcare | $32.34B | $65.47 | −5.61% | +2.44% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | Healthcare | $32.28B | 204.00 EUR | −49.94% | −19.59% |
| ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | $32.12B | $239.00 | −51.77% | −17.13% |
| ZOE.DE | Zoetis Inc. | Healthcare | $32.08B | 65.74 EUR | −51.17% | −4.92% |
| ZTS | Zoetis Inc. | Healthcare | $32.03B | $77.52 | −51.03% | +0.01% |
| Z1TS34.SA | Zoetis Inc. | Healthcare | $32.03B | 24.94 BRL | −53.60% | +0.56% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | Healthcare | $31.78B | 62.25 BRL | −52.98% | −15.31% |
| LH | Labcorp Holdings Inc. | Healthcare | $27.39B | $335.72 | −1.19% | +6.84% |
| R1MD34.SA | ResMed Inc. | Healthcare | $27.33B | 243.85 BRL | −38.58% | 0.00% |
| INSM | Insmed Incorporated | Healthcare | $27.16B | $124.39 | −41.53% | +19.46% |
| DGX | Quest Diagnostics Incorporated | Healthcare | $26.99B | $245.00 | −0.41% | +3.84% |
| INCY | Incyte Corporation | Healthcare | $25.97B | $128.12 | −3.38% | −1.39% |
| I1NC34.SA | Incyte Corporation | Healthcare | $25.83B | 328.02 BRL | −0.20% | +11.19% |
| WST | West Pharmaceutical Services, Inc. | Healthcare | $24.63B | $349.92 | −9.35% | +3.90% |
| STE | STERIS plc | Healthcare | $23.09B | $236.77 | −12.13% | +2.79% |
| GH | Guardant Health, Inc. | Healthcare | $22.94B | $170.92 | −3.21% | +19.01% |
| THC | Tenet Healthcare Corporation | Healthcare | $21.89B | $274.19 | −3.13% | +4.40% |
| S1TE34.SA | STERIS plc | Healthcare | $19.75B | 52.14 BRL | −19.78% | 0.00% |
| VIA.DE | Viatris Inc. | Healthcare | $19.41B | 14.27 EUR | −10.03% | −9.28% |
| VTRS | Viatris Inc. | Healthcare | $19.35B | $16.85 | −8.37% | −5.66% |
| ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $19.34B | $101.38 | −6.38% | +5.88% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | Healthcare | $18.07B | 121.92 BRL | −5.55% | +6.75% |
| MEDP | Medpace Holdings, Inc. | Healthcare | $17.28B | $619.05 | −8.68% | +8.42% |
| NBIX | Neurocrine Biosciences, Inc. | Healthcare | $15.92B | $156.59 | −15.87% | −14.35% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | Healthcare | $15.65B | 39.64 BRL | −13.41% | −10.88% |
| SOLV | Solventum Corporation | Healthcare | $15.58B | $91.53 | −1.27% | +6.22% |
| BBIO | BridgeBio Pharma, Inc. | Healthcare | $15.52B | $79.37 | −15.04% | −7.22% |
| C1OO34.SA | The Cooper Companies, Inc. | Healthcare | $15.12B | 39.92 BRL | −15.06% | +6.97% |
| COO | The Cooper Companies, Inc. | Healthcare | $14.25B | $72.68 | −19.09% | +0.86% |
| CRL | Charles River Laboratories International, Inc. | Healthcare | $14.09B | $295.10 | −1.83% | +22.74% |
| EXEL | Exelixis, Inc. | Healthcare | $14.05B | $56.10 | −2.55% | −0.73% |
| RVTY | Revvity, Inc. | Healthcare | $13.93B | $126.35 | −0.43% | +13.31% |
| BAX | Baxter International Inc. | Healthcare | $13.70B | $26.50 | −11.67% | +8.74% |
| B1AX34.SA | Baxter International Inc. | Healthcare | $13.60B | 67.70 BRL | −7.60% | +8.81% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | $12.95B | $119.80 | −5.21% | +27.19% |
| PEN | Penumbra, Inc. | Healthcare | $12.72B | $323.05 | −10.86% | +0.96% |
| BMRN | BioMarin Pharmaceutical Inc. | Healthcare | $12.70B | $65.61 | −7.57% | +5.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.